In 9M FY25, the operating EBITDA was up 35 per cent YoY to Rs 613 crores
Aster DM Healthcare announced its financial results for the quarter ended December 31, 2024.
Key Financial Highlights
Revenue
· Revenue grew 15 per cent YoY to Rs 3,138 crores in 9M FY25 Vs. Rs 2,721 crores in 9M FY24.
· Revenue grew 11 per cent YoY to Rs 1,050 crores. in Q3 FY25 Vs. Rs 949 crores in Q3 FY24.
EBITDA
· Operating EBITDA grew 35 per cent YoY to Rs 613 crores in 9M FY25 Vs. INR 453 crores in 9M FY24.
· Operating Margins stood at 19.5 per cent in 9M FY25 as compared to 16.6 per cent in 9M FY24.
· Operating EBITDA grew 20 per cent YoY to Rs 202 crores in Q3 FY25 Vs. Rs 168 crores in Q3 FY24.
· Operating EBITDA Margins stood at 19.3 per cent in Q3 FY25 Vs. 17.7 per cent in Q3 FY24.
Profits
· PBT grew by 103 per cent YoY to Rs 413 crores in 9M FY25 Vs. Rs 204 crores in 9M FY24.
· Adjusted Net Profit (post NCI) grew by 65 per cent to Rs 251 crores in 9M FY25 Vs. Rs 153 crores in 9M FY24. Adjusted PAT excludes a one-off merger transaction cost of Rs 23.7 crores.
· The Board of Directors at its meeting held on January 31 2025 approved an interim dividend of Rs 4 per equity share
Dr Azad Moopen, Founder and Chairman, Aster DM Healthcare, said, “We are pleased with the momentum built in the third quarter of FY25, which reflects our unwavering focus on operational excellence and capacity enhancement. For 9M FY25, our India business achieved 15 per cent YoY growth, reaching Rs 3,138 crores, driven by increased patient volumes and growth in ARPOB. The Operating EBITDA grew by 35 per cent YoY to Rs 613 crores and adjusted net profits (post NCI and excluding merger transaction cost) grew by 65 per cent YoY to Rs 251 crores for 9M FY25. A consistent growth across our core businesses, combined with strategic cost optimization, has significantly strengthened our margins with 9MFY25 Operating EBITDA margins at 19.5 per cent.”
Dr Moopen further added, “As we expand, with plans to surpass ~6,800 beds by FY27, Aster DM Healthcare is well-positioned to meet the increasing demand for advanced healthcare in India. I am happy to announce that Aster DM Healthcare was recently honoured at the ASSOCHAM Healthcare Awards 2024, winning the title of “Best Multispecialty Hospital- Group” while Aster DM Foundation secured a first runner up for “Best CSR Excellence in Healthcare”.
